GLUCOACT M*TAB
APPLICATION
GLUCOACT!M
To Resolve
Decreased Insulin Secretion
Increased Insulin Resistance
Gliclazide :
Enhances Insulin Secretion’
Decreases glucose levels by stimulating the release of insulin from 13-cells Improves sensitivity to insulin
Decreases hepatic glucose production.
Me’lformin :
Improves the Action of Insulin3
Increases the glucose uptake in skeletal muscles & adipose tissues
* By direct action * By enhancing the action of insulin
Increases GLUT-4 glucose transporter in insulin sensitive cell
Decreases intestinal glucose absorption.
Improves lipid profile
Promotes weight loss
Retards the progression of macro and microvascular diseases
Low incidences of hypoglycaemia and secondary failures
Safe and well tolerated